Bechir George, Bechir Angelina
Hospital Medicine, Franciscan Health, Munster, USA.
Genetics, Clemson University, South Carolina, Clemson, USA.
Cureus. 2025 May 27;17(5):e84905. doi: 10.7759/cureus.84905. eCollection 2025 May.
Discharging patients with pending microbiology culture results from the hospital has become a common practice aimed at improving hospital throughput and reducing length of stay. One of the main contributors to prolonged hospitalization is the delay in receiving finalized culture results, especially when patients are clinically stable and ready for discharge. Consequently, many hospitals have explored strategies to safely discharge patients before culture results are finalized. While this approach may help alleviate bed shortages and reduce healthcare costs, it raises important patient safety concerns. Finalized culture results may reveal pathogens or resistance patterns that necessitate changes in antimicrobial therapy. Without timely review and action, these findings can lead to missed diagnoses, suboptimal treatment, or avoidable readmissions. This narrative review synthesizes the current evidence on the safety, clinical impact, and system-level strategies associated with discharging patients with pending culture results. Studies show that 2%-11% of pending cultures in hospitalized patients require a change in clinical management, yet documentation of these pending results is often missing from discharge summaries, and follow-up responsibility is frequently unclear. Vulnerable populations, such as older adults and those discharged to subacute care facilities, are particularly at risk due to fragmented transitions and limited outpatient monitoring. Adverse outcomes in these groups include delayed therapy adjustments, inappropriate antimicrobial use, and increased healthcare utilization. To address these risks, several interventions have shown promise. These include electronic health record (EHR)-based alerts, pharmacist-led stewardship programs, and auto-populated discharge summary tools. When integrated into standardized discharge workflows and supported by institutional policy, these interventions improve follow-up rates and reduce harm. Systematic reviews of hospital discharge practices emphasize that multidisciplinary approaches, combining clinical teams, pharmacists, and care transition services, are most effective in ensuring timely review and response to finalized results. In conclusion, discharging patients with pending microbiology cultures can be safe when supported by structured systems that ensure results are reviewed and acted upon after discharge. Hospitals should implement protocols that clearly document pending tests, assign follow-up responsibility, and utilize EHR tools to facilitate communication. These strategies enhance both patient safety and operational efficiency during the vulnerable transition from inpatient to outpatient care.
让微生物培养结果待决的患者出院已成为医院的常见做法,旨在提高医院周转效率并缩短住院时间。住院时间延长的一个主要原因是收到最终培养结果的延迟,尤其是当患者临床状况稳定且准备出院时。因此,许多医院探索了在培养结果最终确定前安全让患者出院的策略。虽然这种方法可能有助于缓解床位短缺并降低医疗成本,但它引发了重要的患者安全问题。最终的培养结果可能揭示需要改变抗菌治疗方案的病原体或耐药模式。如果没有及时审查和采取行动,这些发现可能导致漏诊、治疗不优化或可避免的再次入院。这篇叙述性综述综合了当前关于让培养结果待决的患者出院的安全性、临床影响和系统层面策略的证据。研究表明,住院患者中2%-11%的待决培养结果需要改变临床管理,但出院小结中往往缺少这些待决结果的记录,后续责任也常常不明确。弱势群体,如老年人和那些出院后前往亚急性护理机构的人,由于转诊环节碎片化和门诊监测有限,尤其面临风险。这些人群的不良后果包括治疗调整延迟、抗菌药物使用不当以及医疗利用率增加。为应对这些风险,一些干预措施已显示出前景。这些措施包括基于电子健康记录(EHR)的警报、药剂师主导的管理计划以及自动填充的出院小结工具。当这些干预措施融入标准化出院流程并得到机构政策支持时,可提高后续跟进率并减少伤害。对医院出院实践的系统评价强调,结合临床团队、药剂师和护理转诊服务的多学科方法在确保及时审查和应对最终结果方面最为有效。总之,在有结构化系统支持的情况下,让微生物培养结果待决的患者出院可以是安全的,这些系统可确保出院后对结果进行审查并采取行动。医院应实施明确记录待决检查、指定后续责任并利用EHR工具促进沟通的方案。这些策略在从住院护理到门诊护理的脆弱过渡期间提高了患者安全和运营效率。